Peter Barrett
Chairman at SYNLOGIC, INC.
Net worth: 2 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Prahlad Singh | M | 59 | 10 years | |
| Richard Shea | M | 72 | 21 years | |
| Antoine Awad | M | 44 | 6 years | |
| Mary Dooley | F | 43 | 6 years | |
| Michael Celano | M | 65 | 4 years | |
| Michael Heffernan | M | 59 |
Indalo Therapeutics, Inc.
 Indalo Therapeutics, Inc. BiotechnologyHealth Technology Indalo Therapeutics, Inc. operates as a biopharmaceutical firm that develops integrin antagonists for patients suffering from serious fibrotic diseases such as nonalcoholic steatohepatitis (NASH) and idiopathic pulmonary fibrosis (IPF). The company was founded by David Griggs, Williamson Z. Bradford III, Peter Ruminski, and Robert W. Karr and is headquartered in Cambridge, MA. | 5 years |
| Alexis Michas | M | 66 | 23 years | |
| Joel Goldberg | M | 55 | 16 years | |
| Thomas J. Adam | M | - | 7 years | |
| Samuel Chapin | M | 66 | 8 years | |
| Michel Vounatsos | M | 62 | 4 years | |
| Bruce Booth | M | 49 |
Atlas Venture Life Science Advisors LLC
 Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 10 years |
| Jason Rhodes | M | 54 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 10 years |
| Joseph Truitt | M | 59 | 4 years | |
| Michelle McMurry-Heath | M | 54 | 2 years | |
| Kevin Bitterman | M | 47 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 7 years |
| Maria Fardis | M | 56 |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | 3 years |
| Dave Grayzel | M | 56 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 10 years |
| Ommer Chohan | M | - |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 9 years |
| Thomas Hamilton | M | 56 | 4 years | |
| Ed Mathers Mathers | M | 64 | 12 years | |
| Jonathan Leff | M | 55 | 4 years | |
| Michael Gladstone | M | 37 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 9 years |
| Michael Gilman | M | 69 |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | 8 years |
| Yi Ping Lin | F | - | 1 years | |
| Tajinder Vohra | M | 58 | 9 years | |
| Jodie Morrison | F | 48 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 3 years |
| Pascale Witz | F | 57 | 7 years | |
| Maxwell Krakowiak | M | 35 | 6 years | |
| Nick Leschly | M | 51 | 7 years | |
| Brendan St Amant | M | - | 3 years | |
| Frank R. Witney Witney | M | 70 | 8 years | |
| Bryan A. Kipp | M | - | - | |
| Frank Thomas | M | 54 | 4 years | |
| Sylvie Grégoire | M | 63 | 9 years | |
| Jean-Francois Formela | M | 67 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | 10 years |
| Anita Elberse | M | 51 |
Harvard Business School
| - |
| Robert Ross | M | 50 |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | 4 years |
| Shikhar Ghosh | M | 66 |
Harvard Business School
| 16 years |
| David Scharfstein | M | 63 |
Harvard Business School
| 21 years |
| Fara Goldberg | F | - | - | |
| Anderson Timothy | M | - |
Cadent Therapeutics, Inc.
 Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | - |
| Jayashree Kailas Thacker | F | - | 1 years | |
| Michael Klobuchar | M | 48 | - | |
| Xiangyu Ouyang | M | - |
JenaValve Technology GmbH
 JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Anita Gonzales | F | 48 | 1 years | |
| Magali Four | F | - | 1 years | |
| Miriame Victor | F | 43 | 1 years | |
| Philip Bilden | M | 59 |
Harvard Business School
| - |
| Shashank Singh | M | 47 |
Harvard Business School
| - |
| Erik Amble | M | 72 |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Joshua Harris | M | 59 |
Harvard Business School
| - |
| Patrick van Beneden | M | 62 |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | 14 years |
| William Kirby | M | 72 |
Harvard Business School
| 16 years |
| Lynn Sharp Paine | M | 74 |
Harvard Business School
| 14 years |
| J. Cline | M | 64 |
Harvard Business School
| - |
| Mark McDade | M | 69 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | - |
| Juan Arena de la Mora | M | 80 |
Harvard Business School
| - |
| Douglas Grissom | M | 56 |
Harvard Business School
| - |
| Markus Miele | M | 56 |
Harvard Business School
| - |
| Carl Christian Gilhuus-Moe | M | 80 |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Ankit Mahadevia | M | 43 |
Atlas Venture Life Science Advisors LLC
Atlas Venture Life Science Advisors LLC Investment ManagersFinance Atlas Venture Life Science Advisors LLC (Atlas Venture) is a venture capital firm founded in 2014. The firm is headquartered in Cambridge, Massachusetts. | - |
| Johannes Keltjens | M | 67 |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Olivier Litzka | M | 56 |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Franz Hefti | M | 76 |
Cadent Therapeutics, Inc.
Cadent Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cadent Therapeutics, Inc. develops novel small molecule therapeutics to treat schizophrenia and other cognitive disorders. It focuses on modulating synaptic plasticity, the mechanism through which the brain builds and evolves the synaptic networks that carry out cognitive functions such as learning and memory. The company was founded by Kollol Pal, Frank S. Menniti, and Bertrand Leo Chenard in 2010 and is headquartered in Cambridge, MA. | - |
| Hirotaka Takeuchi | M | 77 |
Harvard Business School
| 48 years |
| James Cash | M | 75 |
Harvard Business School
| 48 years |
| Xiang Yu Ou Yang | M | - |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Sophie Vandebroek | M | 62 | - | |
| Claus Asbjørn Andersson | M | 56 |
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | - |
| Robert Woodman | M | 46 |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Obsidian Therapeutics, Inc. develops cell and gene therapeutics that employ precise exogenous control of transgenes for improved safety and efficacy. The company was founded in 2016 and is headquartered in Cambridge, MA. | 5 years |
| Madhuri Hegde | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Robert Friel | M | 68 | 20 years | |
| Craig Wheeler | M | 63 | 14 years | |
| Stanley Lapidus | M | 75 | 8 years | |
| Hong Zhao | M | 60 | - | |
| Jeffrey Moore | M | 63 | 5 years | |
| Noubar Afeyan | M | 60 | 9 years | |
| Aoife Brennan | M | 48 | 8 years | |
| Stephen J. Lombardi | M | 68 | 4 years | |
| Andrew Okun | M | 54 | 22 years | |
| Ira D. Lawrence | M | 71 | 8 years | |
| David Epstein | M | 65 |
Archemix Corp.
 Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | 2 years |
| Errol de Souza | M | 70 |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | 6 years |
| Stephen Hall | M | 73 | 1 years | |
| Ken Bate | M | 73 |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | 3 years |
| Christoph H. Westphal | M | 56 | 5 years | |
| Ronald Lowy | M | 68 | - | |
| Riccardo Pigliucci | M | 77 |
Perkin Elmer Corp.
 Perkin Elmer Corp. BiotechnologyHealth Technology Perkin Elmer Corp. provides solutions for diagnostics, life sciences, food, and applied markets. The private company is based in Norwalk. The American company's accurate and robust instrumentation and sample handling technologies support the work of regulatory bodies and industry scientists in PPCPs analysis. The company's life sciences products include detection and imaging systems, assays and reagents, automation solutions, informatics platforms, and services. | 3 years |
| Jose-Carlos Gutiérrez-Ramos | M | 61 | 3 years | |
| John Duncan Higgons | M | 69 |
Archemix Corp.
Archemix Corp. Miscellaneous Commercial ServicesCommercial Services Archemix Corp. engages in the research and development of aptamer-based therapeutic products. It focuses in the areas of cardiovascular disease hematology, and oncology. The company was founded in May 2001 and is headquartered in Cambridge, MA. | 3 years |
| Todd Shegog | M | 59 | 3 years | |
| Vicki Sato | M | 75 | 16 years | |
| Elizabeth Stoner | M | 73 | 13 years | |
| Michael Coscia | M | - |
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools. | 6 years |
| Michael Battles | M | 55 | 12 years | |
| Daniel Marshak | M | 67 | 8 years | |
| Kenton Sicchitano | M | 79 | 16 years | |
| Patrick Sullivan | M | 72 | 12 years | |
| Nicholas A. Lopardo | M | 77 | 23 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 92 | 92.00% |
| Germany | 8 | 8.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Peter Barrett
- Personal Network
